Sterling Capital Management
LUCD icon

Sterling Capital Management’s Lucid Diagnostics LUCD Stock Holding History

Sterling Capital Management’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.66K Buy
4,877
+4,355
+834% +$4.07K ﹤0.01% 2990
2026
Q2 		$559 Sell
522
-1,378
-73% -$1.48K ﹤0.01% 3215
2026
Q1 		$2.18K Sell
1,900
-1,096
-37% -$1.4K ﹤0.01% 2975
2025
Q4 		$3.27K Buy
2,996
+124
+4% +$139 ﹤0.01% 2993
2025
Q3 		$2.9K Buy
2,872
+1,734
+152% +$1.89K ﹤0.01% 2919
2025
Q2 		$1.31K Buy
+1,138
New +$1.47K ﹤0.01% 3017

Other funds holding LUCD

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Traphagen Investment Advisors
Traphagen Investment Advisors Oradell, New Jersey $1.46B AUM 14.92% 1-Year Est. Return
Magnus Financial Group
Magnus Financial Group New York $1.5B AUM 16.47% 1-Year Est. Return
Sax Wealth Advisors
Sax Wealth Advisors Parsippany, New Jersey $3.5B AUM 13.72% 1-Year Est. Return
Axxcess Wealth Management
Axxcess Wealth Management Carlsbad, California $2.44B AUM 16.42% 1-Year Est. Return
Obermeyer Wealth Partners
Obermeyer Wealth Partners Aspen, Colorado $2.51B AUM 18.87% 1-Year Est. Return
Anchyra Partners
Anchyra Partners Atlanta, Georgia $477M AUM 34.33% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Quaker Wealth Management
Quaker Wealth Management Moorestown, New Jersey $341M AUM 9.06% 1-Year Est. Return

Sterling Capital Management's LUCD Position: Q3 2026 in Review

Sterling Capital Management increased its Lucid Diagnostics (LUCD) stake by 834% in Q3 2026, buying an estimated $4.07K and bringing the position to 4,877 shares worth $3.66K. The position accounts for ﹤0.01% of the portfolio, ranked #2990.

Sterling Capital Management first reported a position in LUCD in Q2 2025 and has held it in 6 quarters since. 15 funds tracked by Wall St. Rank hold LUCD as of Q3 2026.

  • Sterling Capital Management held 4,877 shares of Lucid Diagnostics worth $3.66K as of Q3 2026.
  • Sterling Capital Management bought 4,355 Lucid Diagnostics shares in Q3 2026, an estimated $4.07K.
  • Lucid Diagnostics made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2990 holding.
  • Sterling Capital Management first reported a position in Lucid Diagnostics in Q2 2025 and has held it in 6 quarters since.
  • 15 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.